306 related articles for article (PubMed ID: 16940442)
1. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
[TBL] [Abstract][Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.
Amory JK; Page ST; Anawalt BD; Matsumoto AM; Bremner WJ
Contraception; 2007 Mar; 75(3):218-23. PubMed ID: 17303493
[TBL] [Abstract][Full Text] [Related]
4. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
7. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
[TBL] [Abstract][Full Text] [Related]
9. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
Bremner WJ; Bagatell CJ; Steiner RA
J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
12. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
13. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive efficacy of a depot progestin and androgen combination in men.
Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
[TBL] [Abstract][Full Text] [Related]
15. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
[TBL] [Abstract][Full Text] [Related]
16. Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men.
Gu YQ; Tong JS; Ma DZ; Wang XH; Yuan D; Tang WH; Bremner WJ
J Clin Endocrinol Metab; 2004 May; 89(5):2254-62. PubMed ID: 15126550
[TBL] [Abstract][Full Text] [Related]
17. Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.
Page ST; Kalhorn TF; Bremner WJ; Anawalt BD; Matsumoto AM; Amory JK
J Androl; 2007; 28(5):734-41. PubMed ID: 17494097
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
19. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.
Behre HM; Kliesch S; Lemcke B; von Eckardstein S; Nieschlag E
Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576
[TBL] [Abstract][Full Text] [Related]
20. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
Pangkahila W
Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
